183.78 USD
↘ 1.49 (0.80%)AT CLOSE (03:59 PM EDT)
Icon Plc
ICLRNASDAQ • USD
183.71
↘ 0.07 (0.04%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
183.71
↘ 0.07 (0.04%)
Market: CLOSED
Icon Plc (ICLR) is currently trading at $183.80. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ICLR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 26, 2026.
Open?$182.08
High?$185.59
Low?$179.16
Prev. Close?$185.27
Volume?1.1M
Avg. Volume?971.4K
VWAP?$183.94
Rel. Volume?1.10x
Bid / Ask
Bid?$180.00 × 500
Ask?$189.00 × 100
Spread?$9.00
Midpoint?$184.50
Valuation & Ratios
Market Cap?14.3B
Shares Out?76.4M
Float?75.9M
Float %?99.5%
P/E Ratio?42.32
P/B Ratio?7.39
EPS?$4.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?66
Momentum?60
Short Sent.?44
Piotroski F-Score?3/9Weak
Altman Z-Score?2.84Safe
Confidence?72%Moderate
Short InterestModerate
Short % of Float?3.91%Low
Short Interest?3.0M
Days to Cover?3.7
Free Float75.9M
Avg Daily Volume799.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.01Strong
Quick Ratio?2.01Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 2 peers + S&P 500
Score56/100
P/E?42.3PRICEY▾
Peers50
S&P17
P/B?7.39FAIR▾
Peers67
S&P25
P/S?4.86FAIR▾
Peers33
S&P30
P/FCF?29.3FAIR▾
Peers67
S&P30
EV/EBITDA?29.2HIGH▾
Peers33
S&P10
EV/Sales?4.66FAIR▾
Peers67
S&P39
Returns & Efficiency
ROE?17.5%STRONG▾
Peers50
S&P61
ROA?9.7%STRONG▾
Peers100
S&P73
Cash Flow & Enterprise
FCF?$488.7M
Enterprise Value?$13.7B
Fundamentals ratios updated end of day